Author Archives: Natalie Themm
Halia Therapeutics co-founder David J. Bearss Featured in Utah Business
Utah Business recently featured Halia Therapeutics co-founder David Bearss in their Founder Series
BD to Present Next Installment of BD Innovates Series: Spotlight on Pharmaceutical Systems
BD to Present Next Installment of BD Innovates Series: Spotlight on Pharmaceutical Systems
Next-Generation Microcatheter for Embolic Agent Delivery Cleared by the FDA
Next-Generation Microcatheter for Embolic Agent Delivery Cleared by the FDA
BD Launches Advanced Vascular Access Ultrasound System Designed to Improve Clinician Efficiency
SiteRite™ 9 Ultrasound System Delivers Enhanced Image Quality and Vessel Assessment Tools to Aid in First Attempt IV Insertion Success
Seek Labs Announces Completion of Office Expansion to Support Business Growth
Seek Labs Announces Completion of Office Expansion to Support Business Growth
Biolexis Therapeutics launches subsidiary Metabolexis to develop novel oral medicines for Obesity and Type 2 Diabetes to improve human longevity
Metabolexis focuses on GLP-1 weight loss and type 2 diabetic drug discoveries to improve accessibility and meet unprecedented demand.
Biolexis Secures $10 Million in Series A Funding to Advance Metabolic Drug Development
LED BY CLARKE CAPITAL, THE NEW FUNDING ROUND WILL ACCELERATE THE COMPANY’S DRUG DISCOVERY PIPELINE
Myriad Genetics Celebrates One Million SneakPeek® Results Shared with Expectant Parents
Myriad Genetics Celebrates One Million SneakPeek® Results Shared with Expectant Parents
Halia Therapeutics Announces Positive Phase 1 Clinical Trial Results for HT-6184 at the 5th Inflammasome Therapeutics Summit
Halia Therapeutics Announces Positive Phase 1 Clinical Trial Results for HT-6184 at the 5th Inflammasome Therapeutics Summit
Myriad Genetics and Personalis Partner to Market Solutions to Pharma Customers
Myriad expands pharma service offering by introducing Personalis’ ImmunoID NeXT® platform to its pharmaceutical partners who use MyRisk® Hereditary Cancer Test, BRACAnalysis CDx® and/or MyChoice® CDx cancer tests
Innovative Research, Inclusive Trials, and New Funding Drives Hope for People with Parkinson’s Disease
PhotoPharmics Secures $16 Million Investment Led by Kickstart to Fund Pivotal Clinical Trial for FDA Market Authorization
Seek Labs Unveils SeekIt™
Seek Labs’ integrated molecular diagnostic platform brings true point-of-care testing to the patient.
